The TWEAK/Fn14 axis was first described ~12 years ago, and since that time studies from around the globe have revealed that Fn14-triggered signal transduction and downstream cellular responses could potentially play a role in the pathophysiology of many major human diseases, including cardiovascular disease, stroke, and cancer. Here, TNFRSF12A is linked to cardiovascular disorder.